Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1383, 2012-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rate-control drugs AFFIRMed, but survival benefit questioned
Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. :
Access to resources
Recommend
The benefit-risk balance of thiomersal-containing vaccines remains overwhelmingly positive
Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. :
PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. :
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
By Cahill Kate Stead Lindsay Lancaster Tim
Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. :